Table 2.
Self-reported prevalence of past-year drug use and self-report of drug-related adverse effects
| Prevalence of Past-Year Use % (n) | Prevalence of Drug Mentioned Within Adverse Outcomes % (n) | Prevalence of Adverse Outcome Relative to Past-Year Use % | Only One Drug Used Before Adverse Outcome % (n) | Multiple Drugs Used Before Adverse Outcome % (n) | |
|---|---|---|---|---|---|
| Alcohol | 81.1 (834) | 67.8 (283) | 33.9 | 61.5 (174) | 38.5 (109) |
| Marijuana | 71.5 (736) | 37.2 (172) | 23.4 | 57.6 (99) | 42.4 (73) |
| Ecstasy/MDMA/Molly | 41.1 (423) | 14.9 (86) | 20.3 | 52.3 (45) | 47.7 (41) |
| Cocaine | 34.0 (350) | 11.4 (88) | 25.1 | 44.3 (39) | 55.7 (49) |
| LSD | 23.1(238) | 10.0 (46) | 19.3 | 43.5 (20) | 56.5 (26) |
| Shrooms (psilocybin) | 21.4 (220) | 3.8 (24) | 10.9 | 75.0 (18) | 25.0 (6) |
| Ketamine | 16.1(166) | 5.0 (32) | 19.3 | 43.8 (14) | 56.3 (18) |
| Poppers (amyl/butyl nitrates) | 14.5 (149) | 1.8(13) | 8.7 | 92.3 (12) | 7.7 (1) |
| Amphetamine | 14.5 (149) | 7.8 (29) | 19.5 | 62.1 (18) | 37.9 (11) |
| Prescription Opioids | 9.9 (102) | 7.7 (42) | 41.2 | 90.5 (38) | 9.5 (4) |
| Benzodiazepines | 7.8 (78) | 2.8 (18) | 23.1 | 66.7 (12) | 33.3 (6) |
| GHB (gamma-hydroxybutyrate) | 4.6 (47) | 1.3 (5) | 10.6 | 80.0 (4) | 20.0 (1) |
| Synthetic Cathinones (“Bath Salts”) | 3.8 (39) | 0.9 (7) | 17.9 | 85.7 (6) | 14.3 (1) |
| Methamphetamine | 3.8 (39) | 1.4 (8) | 20.5 | 62.5 (5) | 37.5 (3) |
| DMT (N,N-Dimethyltryptamine) | 2.8 (28) | 0.2 (4) | 14.3 | 100.0 (4) | 0.0 (0) |
| Synthetic Cannabinoids | 2.5 (25) | 0.2 (3) | 12.0 | 100.0 (3) | 0.0 (0) |
| 2C Series | 2.5 (25) | 0.1 (3) | 12.0 | 66.7 (2) | 33.3 (1) |
| Other MDx (other than MDMA) | 2.4 (24) | 0.8 (4) | 16.7 | 75.0 (3) | 25.0 (1) |
| PCP (Phencyclidine) | 1.9 (20) | 0.3 (3) | 15.0 | 66.7 (2) | 33.3 (1) |
| Novel Dissociatives | 1.5 (15) | 1.2 (4) | 26.7 | 100.0 (4) | 0.0 (0) |
| Unknown powder | 1.2 (12) | 0.1 (2) | 16.7 | 100.0 (2) | 0.0 (0) |
| NBOMe | 0.9 (9) | 0.1 (2) | 22.2 | 50.0 (1) | 50.0 (1) |
| Fentanyl, its Analogs, & New Opioids | 0.8 (8) | 0.1 (4) | 50.0 | 100.0 (4) | 0.0 (0) |
| Heroin | 0.7 (7) | 0.8 (6) | 85.7 | 66.7 (4) | 33.3 (2) |
Note. Prevalence of use of opioids, amphetamine, and benzodiazepines refers to nonmedical use.